Fulcrum Wealth Advisors’s Johnson & Johnson JNJ Stock Holding History

Fulcrum Wealth Advisors’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$527K	Hold	2,076	–	–	0.4%	42
2026 Q1	$507K	Hold	2,076	–	–	0.42%	33
2025 Q4	$430K	Buy	+2,076	New	+$411K	0.35%	41

Other funds holding JNJ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Fulcrum Wealth Advisors's JNJ Position: Q2 2026 in Review

Fulcrum Wealth Advisors held its Johnson & Johnson (JNJ) position steady in Q2 2026 at 2,076 shares worth $527K. The position accounts for 0.4% of the portfolio, ranked #42.

Fulcrum Wealth Advisors first reported a position in JNJ in Q4 2025 and has held it in 3 quarters since. 4,656 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

Fulcrum Wealth Advisors held 2,076 shares of Johnson & Johnson worth $527K as of Q2 2026.
Fulcrum Wealth Advisors left its Johnson & Johnson share count unchanged in Q2 2026.
Johnson & Johnson made up 0.4% of Fulcrum Wealth Advisors's portfolio in Q2 2026, its #42 holding.
Fulcrum Wealth Advisors first reported a position in Johnson & Johnson in Q4 2025 and has held it in 3 quarters since.
4,656 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Fulcrum Wealth Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.